Psychopharmacology pipeline intelligence
Psychopharmacology, in focus.
CNS Pulse tracks the CNS drug-development pipeline and reports from the field — starting with full coverage of conference abstracts, searchable by author, session, and meeting.
Pipeline intelligence
Compounds148
CNS molecules in development — mechanism, phase, and trial evidence.
Indications47
The pipeline by condition, MeSH/ICD-11 coded with subtype hierarchy.
Companies90
Sponsors developing CNS drugs, with ticker, HQ, and pipeline phase.
Targets117
Molecular targets, with every compound in development that acts on each.
Readouts
The catalyst calendar — anticipated and reported trial readouts.
Investigators33
Investigators running trials on tracked compounds, by recruiting activity.
Tracking 222 programs (compound × indication) across 148 compounds.
Conference reports
Conferences2
Structured abstracts by meeting, indexed by session.
Abstracts1733
Every published abstract, searchable across meetings.
Authors1523
Presenting authors, with their abstracts collected.
Articles
Long-form clinical analysis and commentary.
Coming soon
Conferences